MS treatment: Clinical trials due as human stem cells research shows promise
In fact, the process appeared more rapid and efficient than with other cell sources
Steve Connor is the Science Editor of The Independent and i. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; four times highly commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigations into the tobacco industry. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 07 February 2013
The first clinical trials of a revolutionary approach to treating multiple sclerosis with stem cells derived from the patient’s own skin could begin soon following research showing that it works well on laboratory mice, scientists said.
A study has for the first time found that human skin cells converted into stem cells can be used to treat laboratory mice with a condition similar to multiple-sclerosis, where the fatty covering surrounding the nerves is lost.
Scientists in the US said initial clinical trials on human patients using a similar approach could begin in 2015, with full-scale studies soon after. The skin cells were first genetically engineered to become induced pluripotent stem cells (iPS) before being converted to the specialised cells that make the fatty myelin sheaths, which insulate nerve cells in a similar way to the plastic covering of an electrical wire. The myelin is gradually degraded in MS patients.
Scientists were able to turn the iPS cells into oligodendrocyte progenitor cells which were injected into the mice. These progenitor cells went on to become fully specialised oligodendrocytes, the cells responsible for making the myelin sheath.
“The new population of oligodendrocyte progenitor cells and oligodendrocytes was dense, abundant and complete. In fact, they re-myelination process appeared more rapid and efficient than with other cell sources,” said neurologist Steven Goldman of Rochester University Medical Centre in New York. Induced pluripotent stem cells are created by adding several genes to ordinary skin cells. This has the effect of “reprogramming” them back to an earlier, embryonic-like state, but has the ethical advantage over true embyronic stem cells in that they do not require the creation of human embryos.
Clinical trials of human induced pluripotent stem cells on MS patients are being funded by an organisation called New York State Stem Cell Science, which has already approved initial trials using stem cells, which are due to begin within two years.
- 2 Rarest Beanie Baby of them all could be sold for £62,500 on eBay
- 3 Professional big game hunter Ian Gibson crushed to death by elephant during hunt
- 4 Farmer told to tear down mock-Tudor castle after hiding construction behind hay bales
Migrants crossing the Mediterranean: Pope Francis joins calls for EU action on boat refugees
Yemen crisis: Meet the child soldiers who have forsaken books for Kalashnikovs
Alan Rickman admits editing 'terrible' script with friends in Pizza Hut behind backs of writers on Robin Hood: Prince of Thieves
Rarest Beanie Baby of them all could be sold for £62,500 on eBay
Isis in Afghanistan: Group claims responsibility for Jalalabad suicide bombing that killed 35
If I’m being racially abused I don’t need a stranger with a saviour complex to rescue me
The only black face in the Ukip manifesto is on the page about overseas aid
Ukip is the only main political party to not address LGBT rights in its manifesto
Food banks: One million Britons will soon be using them, according to Trussell Trust
Religion isn't growing, it is becoming vigorous in its demise, says philosopher AC Grayling
BBC election debate: The one photo that summed up the whole 90-minute leaders debate
£18000 - £23000 per annum: Recruitment Genius: They work with major vehicle ma...
£16500 per annum: Recruitment Genius: A Chiropractic Assistant is needed in a ...
£18000 - £26000 per annum: Recruitment Genius: They work with major vehicle ma...
£28000 - £30000 per annum: Recruitment Genius: This company provides coaching ...